Catherine Wood's AMGN Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 47.3K shares of Amgen Inc. (AMGN) worth $13.34 M, representing 0.08% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 7 quarters.
Based on 13F filings, Catherine Wood has maintained this position in AMGN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2024, adding 23.2K shares. Largest reduction occurred in Q3 2025, reducing 10.7K shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Catherine Wood
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2024 | +51,666 | New Buy | 51,666 | $284.32 |
| Q2 2024 | +23,155 | Add 44.82% | 74,821 | $312.45 |
| Q3 2024 | +1,793 | Add 2.40% | 76,614 | $322.21 |
| Q4 2024 | -10,240 | Reduce 13.37% | 66,374 | $260.64 |
| Q1 2025 | -7,343 | Reduce 11.06% | 59,031 | $311.55 |
| Q2 2025 | -1,098 | Reduce 1.86% | 57,933 | $279.21 |
| Q3 2025 | -10,668 | Reduce 18.41% | 47,265 | $282.20 |
Catherine Wood's Amgen Investment FAQs
Catherine Wood first purchased Amgen Inc. (AMGN) in Q1 2024, acquiring 51,666 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Amgen Inc. (AMGN) for 7 quarters since Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood's largest addition to Amgen Inc. (AMGN) was in Q1 2024, adding 51,666 shares worth $14.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 47,265 shares of Amgen Inc. (AMGN), valued at approximately $13.34 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Amgen Inc. (AMGN) represents approximately 0.08% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood's peak holding in Amgen Inc. (AMGN) was 76,614 shares, as reported at the end of Q3 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.